3-MMC

Synthetic

3-MMC (3-methylmethcathinone) is a synthetic cathinone and 'research chemical' closely related to mephedrone. It is a short-acting stimulant with mild entactogenic effects, a strong tendency to drive compulsive redosing, and significant risks including cardiovascular toxicity and dependence.

Also known as: 3-methylmethcathinone, Metaphedrone, 3-MMC, Synthetic cathinone, Research chemical / NPS

Written by Psymerge Editorial Team · Last updated June 4, 2026

Key facts

Category
Synthetic
Onset
Snorted: minutes; oral: 15–45 minutes
Peak
30–60 minutes
Total duration
1–3 hours, with a strong urge to redose
After-effects
A comedown with low mood, fatigue, anxiety, and insomnia

Overview

3-MMC (3-methylmethcathinone, also called metaphedrone) is a synthetic cathinone — a class of stimulant 'new psychoactive substances' (NPS) chemically related to the khat plant compound cathinone. It emerged on the recreational market largely to replace its close relative mephedrone (4-MMC) after that drug was banned (Ferreira et al., 2019).

Pharmacologically it acts on the brain's dopamine, norepinephrine, and serotonin systems, producing stimulation, euphoria, increased sociability, and mild feelings of closeness, with a more amphetamine-like profile than MDMA (EMCDDA, 2022). Its effects are relatively short-lived, which strongly encourages repeated dosing within a session and raises the risk of overdose and dependence.

3-MMC is not a traditional or ceremonial substance; it is a recreational research chemical with limited safety data, documented acute toxicity, and a recognised potential for dependence — and it is now legally controlled in many countries (EMCDDA, 2022). This page summarises its pharmacology, effects, and substantial risks.

History & origins

Synthetic cathinones were first synthesised in the twentieth century, but they surged in popularity from around 2010 as 'legal highs' and 'research chemicals' sold online. Mephedrone (4-MMC) was among the most widely used before being banned in many countries; 3-MMC, a positional isomer, was introduced largely as a legal replacement and spread quickly in recreational and 'chemsex' settings (Ferreira et al., 2019).

As use and acute poisonings rose — markedly so in countries such as the Netherlands — regulators responded. Following an EMCDDA risk assessment, the European Union included 3-MMC in its legal definition of a 'drug' in 2022, and many individual countries have placed it under control (EMCDDA, 2022).

Pharmacology & how it works

3-MMC is a synthetic cathinone closely related to mephedrone (4-MMC). Like other cathinones, it acts on the brain's monoamine systems — inhibiting the reuptake of and helping release dopamine, norepinephrine, and serotonin — with a more amphetamine-like profile that affects dopamine and norepinephrine more strongly than serotonin (EMCDDA, 2022; Ferreira et al., 2019). Its strong action on dopamine is associated with a considerable risk of addiction (Simmler et al., 2013).

Chemical class
Synthetic cathinone (stimulant / new psychoactive substance)
Routes of administration
Oral, Insufflated (snorted), Injected (high risk)
Tolerance
Tolerance develops quickly, and the short duration encourages compulsive redosing; 3-MMC has significant abuse liability and dependence potential.

Pharmacokinetics

3-MMC is short-acting, with a rapid onset (especially when snorted) and a brief duration that encourages repeated dosing. Its human pharmacokinetics are poorly studied, with most data coming from case reports and a single animal study (Ferreira et al., 2019).

Effects

Physical Effects

  • Increased heart rate and blood pressure
  • Raised body temperature and sweating
  • Increased energy and wakefulness
  • Jaw clenching and teeth grinding
  • Dilated pupils
  • Reduced appetite

Psychological Effects

  • Euphoria and a sense of wellbeing
  • Increased sociability and talkativeness
  • Mild feelings of empathy or closeness
  • Heightened focus and stimulation
  • A strong urge to redose as the effects fade
  • Anxiety, agitation, or paranoia, especially at high doses or when bingeing

Dosage Information

Low: ~25–50 mg (oral / insufflated)
Medium: ~50–100 mg (oral / insufflated)
High: 100+ mg (oral / insufflated)

As an unregulated research chemical, what is sold as 3-MMC varies in purity and may be a different or stronger cathinone. The short duration strongly encourages redosing, which raises overdose risk. There is no medical or standardised use. Educational only and not an endorsement of use.

Risks & safety

Contraindications

As a powerful stimulant, 3-MMC is inadvisable for:

  • People with cardiovascular conditions or high blood pressure, given its strong effects on heart rate and blood pressure.
  • People with a psychiatric history, particularly psychosis, bipolar disorder, or severe anxiety.
  • People taking serotonergic medications or MAOIs (see interactions below).
  • People with a history of stimulant or other substance use disorder.
  • Pregnant or breastfeeding people.

Drug interactions

3-MMC has dangerous interactions, and combination use is the main pattern in reported deaths (Ferreira et al., 2019).

  • Other stimulants (cocaine, amphetamines, MDMA): sharply increase cardiovascular strain and the risk of overdose and overheating.
  • SSRIs, MAOIs, and other serotonergic drugs: raise the risk of serotonin syndrome.
  • Alcohol and depressants: can mask the stimulant effects and encourage taking more, increasing danger.

This list is not exhaustive, and the uncertain purity of NPS makes interactions harder to predict.

Psychological distress & bad trips

3-MMC commonly causes anxiety, agitation, and paranoia, especially at high doses or during binges, and heavy or repeated use can trigger hallucinations and psychosis (EMCDDA, 2022). The comedown is often harsh, with low mood, exhaustion, and insomnia, which can drive further use.

Rare but serious risks

3-MMC carries significant acute and longer-term risks:

  • Sympathomimetic toxicity: dangerous rises in heart rate, blood pressure, and body temperature, chest pain, agitation, seizures, and in severe cases cardiac arrest (EMCDDA, 2022).
  • Compulsive redosing and addiction: the short duration and strong dopamine action drive bingeing and a real risk of dependence (EMCDDA, 2022; Simmler et al., 2013).
  • Psychiatric harm: anxiety, paranoia, and psychosis, particularly with heavy use.
  • Polydrug deaths: most reported 3-MMC fatalities involved other drugs taken at the same time (Ferreira et al., 2019).
  • Injection-related harms (infections and blood-borne viruses) and a clear risk when driving under the influence.

Vulnerable populations

Some groups face especially high risk and should avoid 3-MMC:

  • People with heart conditions or high blood pressure.
  • People with a personal or family history of psychosis, bipolar disorder, or severe anxiety.
  • People taking serotonergic medications or MAOIs.
  • People with a history of stimulant or other substance use disorder.
  • Adolescents and pregnant or breastfeeding people.

Dependency & addiction potential

3-MMC has a high potential for dependence. Its strong action on dopamine and its short duration encourage compulsive redosing and bingeing, and the EU's risk assessment specifically flagged its abuse liability and dependence-producing potential (EMCDDA, 2022; Simmler et al., 2013). This is in marked contrast to the classic psychedelics, which are not addictive.

Overdose

3-MMC overdose presents as severe sympathomimetic toxicity — extreme agitation, a very high heart rate and blood pressure, dangerous overheating, chest pain, seizures, and potentially fatal cardiac arrest — with the risk greatly increased by combining it with other stimulants or drugs (EMCDDA, 2022). If someone is severely agitated, overheating, has chest pain or seizures, or collapses, seek emergency medical help immediately and tell responders what was taken.

Harm Reduction

  • Remember that NPS purity and identity are uncertain — what is sold as 3-MMC may be a different or stronger cathinone.
  • The short duration drives compulsive redosing: set limits in advance, space out doses, and be aware of the binge risk.
  • Avoid combining with other stimulants, MDMA, cocaine, or serotonergic drugs, which sharply raises cardiovascular and serotonin-toxicity risk.
  • Stay hydrated but not excessively, avoid overheating, and take breaks from intense physical activity.
  • Never inject; if you do, never share equipment.
  • Avoid 3-MMC if you have a heart condition, high blood pressure, or a history of psychosis, anxiety, or stimulant addiction.
  • Do not drive under the influence, and seek help early for chest pain, severe agitation, or overheating.

Cultural & spiritual context

Unlike the plant medicines and classic psychedelics elsewhere on this site, 3-MMC has no traditional, ceremonial, or therapeutic context. It is a modern synthetic stimulant that exists almost entirely within recreational nightlife, party, and 'chemsex' settings, and within the shifting cat-and-mouse market of new psychoactive substances created to stay ahead of drug laws.

This matters for harm reduction: because 3-MMC is unregulated in production, what is sold under its name can vary in purity and identity, and reliable information about long-term effects is scarce. It should be understood as a high-risk recreational drug rather than a tool for healing or growth.

Legal Status

Laws vary widely by country and change frequently, so we don't track legal status here to avoid showing outdated information.

Check current worldwide legal status on Psychedelic Alpha

Frequently asked questions

What is 3-MMC?

3-MMC (3-methylmethcathinone, or metaphedrone) is a synthetic cathinone — a stimulant 'research chemical' closely related to mephedrone (4-MMC), which it was largely introduced to replace after mephedrone was banned (Ferreira et al., 2019).

Is 3-MMC addictive?

Yes. 3-MMC has a high potential for dependence: its strong action on dopamine and its short duration drive compulsive redosing and bingeing, and EU regulators specifically flagged its abuse liability (EMCDDA, 2022; Simmler et al., 2013). This is very different from the classic psychedelics, which are not addictive.

Why do people redose 3-MMC so often?

Its effects are short-lived, typically 1–3 hours, and it acts strongly on dopamine, so users frequently feel a powerful urge to take more as the effects fade. This pattern increases the risk of overdose, dependence, and a harsh comedown.

Why is 3-MMC dangerous?

It can cause severe stimulant (sympathomimetic) toxicity — dangerous rises in heart rate, blood pressure, and temperature, chest pain, seizures, and in severe cases cardiac arrest — as well as anxiety, paranoia, and psychosis. Most reported deaths involved combining it with other drugs (EMCDDA, 2022; Ferreira et al., 2019).

Is 3-MMC legal?

In many countries, no. Following an EMCDDA risk assessment, the European Union included 3-MMC in its legal definition of a 'drug' in 2022, and numerous individual countries have placed it under control (EMCDDA, 2022). Legal status varies by jurisdiction.

Need Integration Support?

Connect with qualified integration guides who can help you process and integrate your experiences safely and effectively.

Find a Guide

Related substances

2C-B

Psychedelic

2C-B is a synthetic psychedelic phenethylamine first made by Alexander Shulgin and structurally related to mescaline. It is strongly dose-dependent: lower doses feel warm, sensual, and entactogen-like (similar to MDMA), while higher doses are clearly psychedelic, with effects lasting about 4–8 hours.

4-AcO-DMT

Psychedelic

4-AcO-DMT (psilacetin, O-acetylpsilocin) is a synthetic tryptamine that acts as a prodrug for psilocin — the same active compound produced by magic mushrooms. Its effects are widely reported to be very similar to psilocybin.

5-MeO-DMT

Psychedelic

5-MeO-DMT is an extremely potent, fast-acting psychedelic tryptamine found in the venom of the Sonoran Desert toad and in some plants, and also made synthetically. Rather than the rich visuals of DMT, it tends to produce a sudden, overwhelming experience of ego dissolution and oneness lasting only minutes.

Ayahuasca

Plant Medicine

Ayahuasca is an Amazonian psychedelic brew that combines a DMT-containing plant with an MAO-inhibiting vine, making the DMT orally active. Used ceremonially for centuries, it produces a long, visionary, and often cathartic experience — typically including purging — lasting around 4–6 hours.

References & further reading

  • European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). (2022). Report on the risk assessment of 3-methylmethcathinone (3-MMC) in accordance with Article 5c of Regulation (EC) No 1920/2006. Lisbon: EMCDDA. https://www.euda.europa.eu/publications/risk-assessments/3-mmc_en
  • Ferreira, B., Dias da Silva, D., Carvalho, F., Bastos, M. de L., & Carmo, H. (2019). The novel psychoactive substance 3-methylmethcathinone (3-MMC or metaphedrone): A review. Forensic Science International, 295, 54–63. https://doi.org/10.1016/j.forsciint.2018.11.024
  • Simmler, L. D., Buser, T. A., Donzelli, M., et al. (2013). Pharmacological characterization of designer cathinones in vitro. British Journal of Pharmacology, 168(2), 458–470. https://doi.org/10.1111/j.1476-5381.2012.02145.x
  • European Union Drugs Agency (EUDA / EMCDDA). New psychoactive substances and drug profiles. https://www.euda.europa.eu/
  • National Institute on Drug Abuse (NIDA). Synthetic Cathinones (Bath Salts). https://nida.nih.gov/research-topics/synthetic-cathinones-bath-salts
  • DanceSafe. https://dancesafe.org/drug-information/
  • TripSit. Drug combinations chart. https://wiki.tripsit.me/wiki/Drug_combinations

About this article

Written by:
PE
Psymerge Editorial Team
Last updated June 4, 2026